Published September 2, 2026 | Version v1

Right Patellar Tendon Repair with Concurrent Regenerative Protocol: A Single-Patient Case Study Documenting ~70% Accelerated Return to Full Knee Function

Authors/Creators

  • 1. Dallas Regenerative Solutions LLC, Dallas, TX

Description

A 51-year-old male sustained a complete right patellar tendon rupture in an e-bike accident (1 May 2026) and underwent primary surgical repair four days later. Beginning on Post-Operative Day 1, the patient independently pursued a regenerative protocol designed by Dr. Peptide (PeptideProtocols.ai), continuing without interruption through the soft-cast period via a window cut in the cast. The protocol included: a two-dose MSC-exosome course totaling 10 cc / 200 billion exosomes (100 billion per 5 cc dose) administered near the injury site on Day −1 and Post-Operative Day 7; a daily oral enteric-coated peptide capsule (BPC-157 + TB-500 + KPV + Larazotide, 1000 mcg total); nightly subcutaneous BPC-Wolverine (BPC-157 + TB-500 + MGF, 10/2.5/1 mg vial, 250 mcg per dose); twice-weekly NAD+ 100 mg; and every-third-day in-clinic PEMF, focused shockwave, and infrared/e-stim at DTX Sports Medicine under Dr. Will Hurtado, DC, with supervised rehabilitation. The patient demonstrated active knee flexion out of the Rebound hinged brace at Post-Operative Day 22, completed full stationary-bike pedal revolutions at Day 29, and single-leg weight-bearing on the operative limb at Day 31. Both functional milestones occurred approximately three weeks ahead of the Massachusetts General Brigham Sports Medicine rehabilitation protocol and the West et al. early-mobilization timeline reviewed in the 2024 JAAOS update. All photographs carry independent date markings for reader verification. Reported as a single-patient observation.

Files

Crowder_PatellarTendonRepair_CaseStudy_FINAL.pdf

Files (7.5 MB)

Name Size
md5:f2665f1357bad7cad2b01c65c7fb7917
7.5 MB Preview Download

Additional details

Related works

Is supplemented by
Other: https://peptideprotocols.ai (URL)